for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Business

FDA narrows label for Biogen’s Alzheimer’s drug

Posted

[NFA] Biogen said on Thursday the U.S. Food and Drug Administration has approved changes to product information on its Alzheimer's disease drug, effectively narrowing the target population. Fred Katayama reports.

Business

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up